Form 4: Adma Biologics COO Reports Stock Transaction
Insider Transaction (Form 4)
Kaitlin M. Kestenberg-Messina, COO and SVP, Compliance of Adma Biologics, Inc., reported a transaction in 3,177 shares of common stock on July 24, 2026.
Summary
- Tax/exercise-price withholding: disposed of 3,177 Common Stock at $8.37 ($26,591) on July 24, 2026; holds 443,061 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Kaitlin M. Kestenberg-Messina — Officer (COO and SVP, Compliance)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-24 | Tax/exercise-price withholding | Common Stock | 3,177 | $8 | $26.6K | 443,061 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-24 | Tax/exercise-price withholding (3,177 shares) |
Keywords
insider transaction, Form 4, ADMA, ADMA BIOLOGICS, INC., neutral, Kaitlin M. Kestenberg-Messina
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.